Role of ERK1/2 activation in thrombin-induced vascular smooth muscle cell hypertrophy

Current Hypertension Reviews

Volumn 4, Issue 3, 2008, Pages 190-196

  Isenovic, Esma R ^a   Trpkovic, Andreja ^a   Zakula, Zorica ^a   Koricanac, Goran ^a   Marche, Pierre ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

Calcium channels; Epidermal growth factor receptor; ERK1 2 signaling pathway; Hypertrophy; Thrombin; Vascular smooth muscle cells

Indexed keywords

EID: 54749108385     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340208785132590     Document Type: Review

References (83)

1. Mulvany MJ, Hansen OK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43: 854-64.
2. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347-504.
3. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570-81.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
5. Campbell JH, Black MJ, Campbell GR. Replication of smooth mucle vessel cells in atherosclerosis and hypertension. In: Meyer P, Marche P, Eds, Blood cells and arteries in hypertension and atherosclerosis. New York, Raven Press, 1989; 19: 15-33.
6. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension 1998; 31: 152-61.
7. Stern DF. ErbBs in mammary development. Exp Cell Res 2003; 284: 89-98.
8. Troyer KL, Lee DC. Regulation of mouse mammary gland development and tumorigenesis by the ErbB signaling network. J Mammary Gland Biol Neoplasia 2001; 6: 7-21.
9. Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. Embo J 2000; 19: 3159-67.
10. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2: 127-37.
11. Boonstra J, Rijken P, Humbel B, Cremers F, Verkleij A, van Bergen en Henegouwen P. The epidermal growth factor. Cell Biol Int 1995; 19: 413-30.
12. Cohen S, Carpenter G, King L, Jr. Epidermal growth factor-receptor-protein kinase interactions. Prog Clin Biol Res 1981; 66: 557-67.
13. Berk BC, Brock TA, Webb RC, et al. Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J Clin Invest 1985; 75: 1083-6.
14. Mitsumata M, Gamou S, Shimizu N, Yoshida Y. Response of atherosclerotic intimal smooth muscle cells to epidermal growth factor in vitro. Arterioscler Thromb 1994; 14: 1364-71.
15. Gui Y, Zheng XL. Epidermal growth factor induction of phenotype-dependent cell cycle arrest in vascular smooth muscle cells is through the mitogen-activated protein kinase pathway. J Biol Chem 2003; 278: 53017-25.
16. Whitmarsh AJ, Davis RJ. A central control for cell growth. Nature 2000; 403: 255-6.
17. 2+- and protein kinase C-dependent stimulation of mitogen-activated protein kinase in detergent-skinned vascular smooth muscle. J Cell Physiol 1999; 179: 208-17.
18. Zhang YZ, Gao PJ, Wang XY, et al. The inhibitory mechanisms of amlodipine in human vascular smooth muscle cell proliferation. Hypertens Res 2000; 23: 403-6.
19. Cowley S, Paterson H, Kemp P, Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994; 77: 841-52.
20. Marche P, Herembert T, Zhu DL. Molecular mechanisms of vascular hypertrophy in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1995; 22: S114-6.
21. Yamori Y, Igawa T, Kanbe T, Kihara M, Nara Y, Horie R. Mechanisms of structural vascular changes in genetic hypertension: analyses on cultured vascular smooth muscle cells from spontaneously hypertensive rats. Clin Sci (Lond) 1981; 61: 121s-123s.
22. Hadrava V, Tremblay J, Hamet P. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension 1989; 13: 589-97.
23. Zhu DL, Herembert T, Marche P. Increased proliferation of adventitial fibroblasts from spontaneously hypertensive rat aorta. J Hypertens 1991; 9: 1161-8.
24. Saltis J, Bobik A. Vascular smooth muscle growth in genetic hypertension: evidence for multiple abnormalities in growth regulatory pathways. J Hypertens 1992; 10: 635-43.
25. Touyz RM, Deschepper C, Park JB, He G, et al. Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-inducrd contractility of mesenteric resistance arteries from spontaneously hypertensive rats. J Hypertens 2002; 20: 1127-34.
26. Touyz RM, He G, El Mabrouk M, Diep Q, Mardigyan V, Schiffrin EL. Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats. J Hypertens 2001; 19: 553-9.
27. Matrougui K, Eskildsen-Helmond YEG, Fiebeler A, et al. Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries. Hypertension 2000; 36: 617-21.
28. El Mabrouk M, Touyz RM, Schiffrin EL. Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. Am J Physiol Heart Circ Physiol 2001; 281: H30-H39.
29. Touyz RM, Wu XH, He G, Salomon S, Schiffrin EL. Increased Angiotensin II-Mediated Src Signaling via Epidermal Growth Factor Receptor Transactivation Is Associated With Decreased C-Terminal Src Kinase Activity in Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats. Hypertension 2002; 39: 479-85.
30. 2/calmodulin-sensitive tyrosine kinase. J Biol Chem 1996; 271: 14169-75.
31. Stepien O, Gogusev J, Zhu DL, et al. Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation. J Cardiovasc Pharmacol 1998; 31: 786-93.
32. Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension 1992; 20: 713-36.
33. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW, 2nd, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993; 91: 94-8.
34. Glusa E. Vascular effects of thrombin. Semin Thromb Hemost 1992; 18: 296-304.
35. Fager G. Thrombin and proliferation of vascular smooth muscle cells. Circ Res 1995; 77: 645-50.
36. McNamara CA, Sarembock IJ, Bachhuber BG, et al. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis. Semin Thromb Hemost 1996; 22: 139-44.
37. Molloy CJ, Pawlowski JE, Taylor DS, Turner CE, Weber H, Peluso M. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein-coupled receptor agonist. J Clin Invest 1996; 97: 1173-83.
38. Pouyssegur J, Seuwen K. Transmembrane receptors and intracellular pathways that control cell proliferation. Annu Rev Physiol 1992; 54: 195-210.
39. Zwick E, Hackel PO, Prenzel N, Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci 1999; 20: 408-12.
40. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999; 402: 884-8.
41. Kalmes A, Vesti BR, Daum G, Abraham JA, Clowes AW. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res 2000; 87: 92-8.
42. Bobe R, Yin X, Roussanne MC, et-al. Evidence for ERK1/2 activation by thrombin that is independent of EGFR transactivation. Am J Physiol Heart Circ Physiol 2003; 285: H745-54.
43. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996; 379: 557-60
44. Wang H, Ubl JJ, Stricker R, Reiser G. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am J Physiol Cell Physiol 2002; 283: C1351-64.
45. Eguchi S, Numaguchi K, Iwasaki H, et al. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 1998; 273: 8890-6.
46. Ginnan R, Singer HA. CaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle. Am J Physiol Cell Physiol 2002; 282: C754-61.
47. Zwick E, Wallasch C, Daub H, Ullrich A. Distinct calcium-dependent pathways of epidermal growth factor receptor transactivation and PYK2 tyrosine phosphorylation in PC12 cells. J Biol Chem 1999; 274: 20989-96.
48. Chen YH, Pouyssegur J, Courtneidge SA, Van Obberghen-Schilling E. Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive fibroblasts. J Biol Chem 1994; 269: 27372-7.
49. Schieffer B, Drexler H, Ling BN, Marrero MB. G protein-coupled receptors control vascular smooth muscle cell proliferation via pp60c-src and p21ras. Am J Physiol 1997; 272: C2019-30.
50. Vaingankar SM, Martins-Green M. Thrombin aivation of the 9E3/CEF4 chemokine involves tyrosine kinases including c-src and the epidermal growth factor receptor. J Biol Chem 1998; 273: 5226-34.
51. Blaukat A, Ivankovic-Dikic I, Gronroos E, et al. Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades. J Biol Chem 1999; 274: 14893-901.
52. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 1996; 383: 547-50.
53. Kanda Y, Mizuno K, Kuroki Y, Watanabe Y. Thrombin-induced p38 mitogen-activated protein kinase activation is mediated by epidermal growth factor receptor transactivation pathway. Br J Pharmacol 2001; 132: 1657-64.
54. Ishida M, Ishida T, Thomas SM, Berk BC. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 1998; 82: 7-12.
55. Ishida T, Ishida M, Suero J, Takahashi M, Berk BC. Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J Clin Invest 1999; 103: 789-97.
56. 2+ signaling by angiotensin II in human vascular smooth muscle cells. J Hypertens 2001; 19: 441-9.
57. Ward CW, Gough KH, Rashke M, Wan SS, Tribbick G, Wang J. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. J Biol Chem 1996; 271: 5603-9.
58. Coffer PJ, Kruijer W. EGF receptor deletions define a region specifically mediating STAT transcription factor activation. Biochem Biophys Res Commun 1995; 210: 74-81.
59. Helin K, Beguinot L. Internalization and down-regulation of the human epidermal growth factor receptor are regulated by the carboxyl-terminal tyrosines. J Biol Chem 1991; 266: 8363-8.
60. Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol 2000; 12: 186-92.
61. Yu Z, Ahmad S, Schwartz JL, Banville D, Shen SH. Protein-tyrosine phosphatase SHP2 is positively linked to proteinase-activated receptor 2-mediated mitogenic pathway. J Biol Chem 1997; 272: 7519-24.
62. 2+ store depletion in rat liver epithelial cells. Am J Physiol 1999; 276: C221-30.
63. Hughes AD. Calcium channels in vascular smooth muscle cells. J Vasc Res 1995; 32: 353-70.
64. Gollasch M, Haase H, Ried C, et al. L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J 1998; 12: 593-601.
65. Short AD, Bian J, Ghosh TK, Waldron RT, Rybak SL, Gill DL. Intracellular Ca2+ pool content is linked to control of cell growth. Proc Natl Acad Sci USA 1993; 90: 4986-90.
66. Berridge MJ. Calcium signalling and cel proliferation. Bioessays 1995; 17: 491-500.
67. Hirata A, Igarashi M, Yamaguchi H, et al. Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK-ERK pathway coupling with Pyk2. Br J Pharmacol 2000; 131: 1521-30.
68. McMurray HF, Chahwala SB. Amlodipine exerts a potent antimigrational effect on aortic smooth muscle cells in culture. J Cardiovasc Pharmacol 1992; 20: S54-6.
69. Jackson CL, Bush RC, Bowyer DE. Mechanism of antiatherogenic action of calcium antagonists. Atherosclerosis 1989; 80: 17-26.
70. Ko Y, Totzke G, Graack GH, et al. Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells. J Hypertens 1993; 11: 1171-8.
71. Pitt B, Byington RP, Furberg CD, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000; 102: 1503-10.
72. Mancini GB. Antiatherosclerotic effects of calcium channel blockers. Prog Cardiovasc Dis 2002; 45: 1-20.
73. Corsini A, Bonfatti M, Quarato P, et al. Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes. J Cardiovasc Pharmacol 1996; 28: 687-94.
74. 2+ channels. Kidney Int 1996; 49: 868-79.
75. 2+ stores in thrombin-stimulated vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2000; 279: H1220-7.
76. Stepien O, Zhang Y, Zhu D, Marche P. Dual mechanism of action of amlodipine in human vascular smooth muscle cells. J Hypertens 2002; 20: 95-102.
77. 2--ATPase regulation. J Biol Chem 1996; 271: 27788-94.
78. Simon VR, Moran MF. SERCA activity is required for timely progression through G1/S. Cell Prolif 2001; 34: 15-30.
79. Waldron RT, Short AD, Meadows JJ, Ghosh TK, Gill DL. Endoplasmic reticulum calcium pump expression and control of cell growth. J Biol Chem 1994; 269: 11927-33.
80. Rosen LB, Ginty DD, Weber MJ, Greenberg ME. Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron 1994; 12: 1207-21.
81. Mulvaney JM, Zhang T, Fewtrell C, Roberson MS. Calcium influx through L-type channels is required for selective activation of extracellular signal-regulated kinase by gonadotropin-releasing hormone. J Biol Chem 1999; 274: 29796-804.
82. Yin X, Polidano E, Faverdin C, Marche P. Role of L-type calcium channel blockingin epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2. J Hypertens. 2005; 23(2): 337-50.
83. Henry PD. Antiperoxidative actions of calcium antagonists and atherogenesis. J Cardiovasc Pharmacol 1991; 18: S6-10.